LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.56234
70.05 770.25 1549 10413 0.1488 0.2044
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
70.05 770.25 1260 10413 0.1210 0.1400
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
72.27 770.25 1481 10730 0.1380 0.1877
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
72.27 770.25 1415 10730 0.1319 0.1736
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
74.50 770.25 1592 10991 0.1448 0.2084
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
74.50 770.25 1486 10991 0.1352 0.1869
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
76.75 770.25 1830 11262 0.1625 0.2506
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
76.75 770.25 1616 11262 0.1435 0.2110
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
78.98 770.25 1878 11518 0.1631 0.2566
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
78.98 770.25 1619 11518 0.1406 0.2097
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
81.20 770.25 1899 11766 0.1614 0.2579
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
81.20 770.25 1568 11766 0.1333 0.1981
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
83.42 770.25 1760 12031 0.1463 0.2317
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
83.42 770.25 1848 12031 0.1536 0.2469
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
85.64 770.25 1976 12287 0.1608 0.2659
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
85.64 770.25 1722 12287 0.1401 0.2231
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
0.56234
87.86 770.25 1955 12543 0.1559 0.2603
MN20160304_L02
K12
MCF 10A-H2B-mCherry Neratinib
0.56234
87.86 770.25 1883 12543 0.1501 0.2487
MN20160304_L02
M11
MCF 10A-H2B-mCherry Neratinib
1
3.21 770.25 929 904 1.0269 1.2429
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
3.21 770.25 1157 904 1.2790 4.7765
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
5.44 770.25 965 1012 0.9529 0.7698
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
5.44 770.25 1237 1012 1.2214 2.3190
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
7.66 770.25 1000 1090 0.9174 0.6839
MN20160304_L02
E14
MCF 10A-H2B-mCherry Neratinib
1
7.66 770.25 1311 1090 1.2028 1.8912
MN20160304_L02
J12
MCF 10A-H2B-mCherry Neratinib
1
10.06 770.25 1049 1218 0.8609 0.5949
MN20160304_L02
E14